Back to Results
First PageMeta Content
Bioequivalence / Clinical research / Research / GVK Biosciences


London, 30 July 2014 Doc. Ref.: EMA/CMDh[removed]To: Marketing Authorisation Holders (MAHs) / Applicants Dear Madam/Sir,
Add to Reading List

Document Date: 2014-07-30 11:29:28


Open Document

File Size: 90,49 KB

Share Result on Facebook

City

Hyderabad / London / /

Company

GVK Biosciences Private Limited / Agency for Medicines / Health / /

Country

Germany / Romania / Hungary / Netherlands / Croatia / Italy / Estonia / Slovenia / Bulgaria / Cyprus / Latvia / Sweden / Poland / Norway / Belgium / France / Iceland / Portugal / Slovakia / United Kingdom / Malta / Lithuania / Luxembourg / Finland / Spain / Greece / India / Ireland / Denmark / Czech Republic / /

/

Facility

GVK Bio Hyderabad facility / Canary Wharf / /

NaturalFeature

mt Netherlands / /

Organization

Agency for Medicines and Health Products Safety / National Competent Authority / /

/

Position

gov. uk Page / gov. it Latvia monta.emersone@zva.gov.lv Lithuania zydrunasmartinenas@vvkt.lt / Governor / Chair / /

URL

www.ema.europa.eu / /

SocialTag